Life In The DPC!

I absolutely tanked by picking the Cleveland Cavaliers over the Spurs in six. In reality I have had a bad run of luck in my latest wagers:

• Nevada to go to the Sweet Sixteen and they were eliminated in the second round by Memphis
  
• Chicago Bears over the Colts and I watched the horror of Peyton’s first championship
  

These last three picks have shown me once again that I need to use my head as opposed to my heart to place wagers. But in my defense I really thought the Bears could knock off the Colts. Any who, as we begin a quiet period for sports championships I can lick my wounds and reflect on how I can avoid these mistakes in the coming years.

Despite my recent defeats in wagering I had a pretty good before this drought:

• Florida over Ohio State in the BCS
• Arizona Cardinals over the 49ers (twice)
• Miami over Nevada (not a real shock

(Note: I don’t count my inability to judge NFL talent. David Klingler, Andre Ware and Jeff George were not flops. They were drafted by the wrong teams)
Even with my misguided gambling I have recently felt the need to break into the stock market. Truthfully I have no idea where this notion came from but on a random weekday at 6:45 am I became a member of Bank Of America’s investing branch. I think the wheels were set in motion by chatting about investments, or my lack of any retirement cash, with English Sarah from work. Apparently she realized that the future can be a bit better if you have some cash to live on but I had managed to ignore this notion for 29 years.

Due to fiscal realities I have budgeted myself to $50.00 per week in stock trades, including the various fees tacked onto each trade. With drastic budget restraints I find myself doing more research and trying to arbitrarily decipher the winners and losers. At this early stage I have only acquired a pair of stocks:

1. Viral Genetics (VRAL.OB) 200 shares at $.04 each. Viral Genetics, Inc. is a biotechnology company that discovers and develops immune-based therapies for HIV and AIDS using its thymus nuclear protein compound. This compound may have other potential applications for other infectious, autoimmune, and immunological deficiency diseases that the company intends to study in the future. Viral Genetics believes that VGV-1 represents a significant and unique approach to treating HIV due to the apparently novel mechanism, low toxicity profile, simple dosing regimen, and short-course of treatment.
2. Ask Me Now, INC (AKMN.OB) 20 shares at $.71. AskMeNow is committed to keeping you in the know while on the go. Through our groundbreaking technology, you can get quick and easy access to 411 listings, Weather, Movie Times, Sports Scores, Directions, Horoscopes, Travel Information, Stock Quotes and more — all from your cell phone within moments. We have all the answers

So far I have made 40 cents…